NeoGenomics (NASDAQ:NEO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
NeoGenomics beat estimated earnings by 27.27%, reporting an EPS of $-0.16 versus an estimate of $-0.22.
Revenue was up $3.35 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 6.61% drop in the share price the next day.
Here's a look at NeoGenomics's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|
| EPS Estimate | -0.22 | -0.23 | -0.14 | -0.09 | -0.06 |
| EPS Actual | -0.16 | -0.20 | -0.14 | -0.08 | -0.01 |
| Revenue Estimate | 123.37M | 116.68M | 125.78M | 125.05M | 118.16M |
| Revenue Actual | 125.07M | 117.17M | 125.73M | 121.34M | 121.72M |
To track all earnings releases for NeoGenomics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
